Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients

Heart

Volumn 80, Issue 4, 1998, Pages 377-382

  O'Keeffe, S T ^a,b   Lye, M ^a   Donnellan, C ^a   Carmichael, D N ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (Ireland)

Author keywords

Elderly people; Heart failure; Quality of life; Six minute walk

Indexed keywords

AGED; ARTICLE; CORRELATION FUNCTION; EXERCISE TEST; GERIATRIC CARE; HEART FAILURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION PROCESS;

EID: 0031689593     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.80.4.377     Document Type: Article

References (32)

1. Lee DC-S, Johnson RA, Bingham JB, et al. Heart failure in outpatients. A randomized trial of digoxin versus placebo. N Engl J Med 1982;306:699-705.
2. Guyatt GH, Sullivan MJJ, Fallen EL, et al. A controlled trial of digoxin in congestive heart failure. Am J Cardiol 1988;61:371-5.
3. Rector TS, Johnson G, Dunkman WB, et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorhide dinitrate on quality of life: V-HeFT II. Circulation 1993;87:VI-71-7.
4. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
5. Streiner DL, Norman GR. Health measurement scales, 2nd ed. Oxford: Oxford Medical Publications, 1995.
6. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121:951-7.
7. Lipkin D, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1986;292:653-5.
8. Guyatt GH, Nogradi S, Halcrow S, et al. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med 1989;4:101-7.
9. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-22.
10. McKee PA, Castelli WP, McNamara M, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971;285:1441-6.
11. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6 minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.
12. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep 1966;19:3-11.
13. Shrout PE, Fleiss JL. Intraclass correlations: uses in inter-rater reliability. Psychol Bull 1979;86:420-8.
14. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997;50:79-93.
15. Cohen J. Statistical power analysis for the behavioural sciences, 2nd ed. New Jersey: Lawrence Erlbaum Associates, 1988.
16. Guyatt G, Walter S, Norman G. Measuring change over time - assessing the usefulness of evaluative instruments. J Chron Dis 1987;40:171-8.
17. Jaeschke R, Singer J, Guyatt GH. Measurement of health-status - ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
18. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms - a comparison of 2 techniques. J Clin Epidemiol 1996;49:1215-19.
19. Jitapunkul S, Pillay I, Ebrahim S. The abbreviated mental test - its use and validity. Age Ageing 1991;20:332-6.
20. O'Keeffe ST, Lye M. Heart failure in the elderly: the same syndrome as the clinical trials? In: McMurray JJV, Cleland JGF, eds. Heart failure in clinical practice. London: Martin Dunitz, 1996:47-71.
21. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273: 1450-6.
22. Welch HG, Albertsen PC, Nease RF, et al. Estimating treatment benefits for the elderly - the effect of competing risks. Ann Intern Med 1996;124:577-84.
23. Yusuf S, Tsuyuki R. Using exercise end points in heart failure trials: design considerations. Eur Heart J 1996;17:4-6.
24. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left-ventricular dysfunction. JAMA 1993;270:1702-7.
25. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley and Sons, 1986.
26. McHorney CA, Tarlov AR. Individual patient monitoring in clinical practice: are available health status surveys enough? Qual Life Res 1995;4:293-307.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet 1986;i:307-10.
28. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health-status measures - statistics and strategies for evaluation. Control Clin Trials 1991;12:S142-58.
29. Bombardier C, Raboud J. A comparison of health-related quality-of-life measures for rheumatoid-arthritis research. Control Clin Trials 1991;12:S243-56.
30. Siu AL, Ouslander JG, Osterweil D, et al. Change in self-reported functioning in older persons entering a residential care facility. J Clin Epidemiol 1993;46:1093-101.
31. Jenkinson C, Jenkinson D, Shepperd S, et al. Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). Age Ageing 1997;26:7-13.
32. Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical-change - an analogy to diagnostic-test performance. J Chron Dis 1986;39:897-9 06.